News

Featured

Dec 17, 2024 - Feature

2024 Wrapped: Progress, partnerships and possibilities

As 2024 draws to a close, we reflect on a transformative year for the UK DRI.

Learn more 2024 Wrapped: Progress, partnerships and possibilities

Bill Wisden giving a talk at connectome 2023

Dec 17, 2024 - Update

Welcoming a new Centre Director to the UK DRI at Imperial

We are pleased to announce that our new Centre Director for the UK DRI at Imperial is Prof William Wisden, an expert in the study...

Learn more Welcoming a new Centre Director to the UK DRI at Imperial

Dec 13, 2024 - Research

How DNA markers influence gene expression in different cells and tissues

A new study, led by Dr Sarah Marzi (UK DRI at King’s) and Alan Murphy (UK DRI at Imperial), reveals key insight into how gene...

Learn more How DNA markers influence gene expression in different cells and tissues

Search for news

Oct 28, 2019 - Blog

Successful transplantation of human microglia paves way for next generation of research models

A new article from the lab of Prof Bart De Strooper in VIB Leuven has...

Learn more Successful transplantation of human microglia paves way for next generation of research models

Oct 22, 2019 - Blog

Milestone in search for dementia treatment as Biogen files for FDA approval of aducanumab

In exciting news for the dementia field, it has today been announced by Biogen and...

Learn more Milestone in search for dementia treatment as Biogen files for FDA approval of aducanumab

Oct 21, 2019 - Blog

Inspirational fundraiser visits UK DRI at Cambridge on journey around the UK

On Thursday 10 October Alzheimer’s Society fundraiser Hannah Mackay visited Dr Gabriel Balmus at UK...

Learn more Inspirational fundraiser visits UK DRI at Cambridge on journey around the UK

Oct 17, 2019 - Blog

UK DRI responds to announcement that Eli Lilly is ending neuroscience research in the UK

US-based pharmaceutical company Eli Lilly have announced that they will close their research and development...

Learn more UK DRI responds to announcement that Eli Lilly is ending neuroscience research in the UK

Oct 14, 2019 - Blog

Connectome 2019 – Binding minds

With over 300 researchers, students and support staff attending the UK DRI’s annual conference, Connectome...

Learn more Connectome 2019 – Binding minds

Oct 08, 2019 - Blog

Official Centre Opening: Cutting the ribbon at UK DRI at Cambridge

Over 180 researchers, clinicians and students gathered last month (23 September) for the official opening...

Learn more Official Centre Opening: Cutting the ribbon at UK DRI at Cambridge

Oct 02, 2019 - Blog

Dementia Revolution raises £4 million for UK DRI, setting new record for London Marathon Charity of the Year Partnership

Latest fundraising figures reveal that the Dementia Revolution has now raised a record-breaking £4 million...

Learn more Dementia Revolution raises £4 million for UK DRI, setting new record for London Marathon Charity of the Year Partnership

Sep 26, 2019 - Blog

Our highlights from the ARUK Conference 2019

Between 19-20th March, over 500 delegates came together in the small town of Harrogate in...

Learn more Our highlights from the ARUK Conference 2019

Sep 26, 2019 - Blog

Disappointment as phase III aducanumab trials for Alzheimer’s disease stopped early

It was announced yesterday (Thursday 21st March) that pharmaceutical companies Biogen and Eisai are to...

Learn more Disappointment as phase III aducanumab trials for Alzheimer’s disease stopped early

Sep 26, 2019 - Blog

The Princess Royal visits UK Dementia Research Institute at UCL

During the visit, The Princess met with our directors to hear about their vision for...

Learn more The Princess Royal visits UK Dementia Research Institute at UCL

Sep 26, 2019 - Blog

UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI

UK DRI fellow at UCL, Dr Marc Aurel Busche, has been named as a recipients...

Learn more UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI

Sep 26, 2019 - Blog

Promising Huntington’s drug trial results shared after over a decade’s work

The full results from a ground-breaking trial showing successful lowering of a toxic protein in...

Learn more Promising Huntington’s drug trial results shared after over a decade’s work

Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders

Why partner with the UK DRI?

Why join the UK DRI?

Featured

2024 Wrapped: Progress, partnerships and possibilities

Welcoming a new Centre Director to the UK DRI at Imperial

How DNA markers influence gene expression in different cells and tissues

Search for news

Successful transplantation of human microglia paves way for next generation of research models

Milestone in search for dementia treatment as Biogen files for FDA approval of aducanumab

Inspirational fundraiser visits UK DRI at Cambridge on journey around the UK

UK DRI responds to announcement that Eli Lilly is ending neuroscience research in the UK

Connectome 2019 – Binding minds

Official Centre Opening: Cutting the ribbon at UK DRI at Cambridge

Dementia Revolution raises £4 million for UK DRI, setting new record for London Marathon Charity of the Year Partnership

Our highlights from the ARUK Conference 2019

Disappointment as phase III aducanumab trials for Alzheimer’s disease stopped early

The Princess Royal visits UK Dementia Research Institute at UCL

UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI

Promising Huntington’s drug trial results shared after over a decade’s work